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Abstract
Introduction Developmental venous anomalies (DVA) con-
sist of dilated intramedullary veins that converge into a
large collecting vein. The appearance of these anomalies
was evaluated on whole-brain computed tomography (CT)
digital subtraction angiography (DSA) and CT perfusion
(CTP) studies.
Methods CT data sets of ten anonymized patients were
retrospectively analyzed. Five patients had evidence of DVA
and five age- and sex-matched controls were without known
neurovascular abnormalities. CT angiograms, CT arterial-
venous views, 4-D CT DSA and CTP maps were acquired on
a dynamic volume imaging protocol on a 320-detector row
CTscanner. Whole-brain CTP parameters were evaluated for
cerebral blood flow (CBF), cerebral blood volume (CBV),
time to peak (TTP), mean transit time (MTT), and delay.
DSAwas utilized to visualize DVA anatomy. Radiation dose
was recorded from the scanner console.
Results Increased CTP values were present in the DVA
relative to the unaffected contralateral hemisphere of 48%,
32%, and 26%; and for the control group with matched
hemispheric comparisons of 2%, −10%, and 9% for CBF,
CBV, and MTT, respectively. Average effective radiation
dose was 4.4 mSv.
Conclusion Whole-brain DSA and CTP imaging can
demonstrate a characteristic appearance of altered DVA
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hemodynamic parameters and capture the anomalies in
superior cortices of the cerebrum and the cerebellum.
Future research may identify the rare subsets of patients at
increased risk of adverse outcomes secondary to the altered
hemodynamics to facilitate tailored imaging surveillance
and application of appropriate preventive therapeutic measures.
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Introduction
Developmental venous anomalies (DVA) represent a nor-
mal variant that may be associated with other cerebral
vascular malformations. DVA have been previously re-
ferred to as venous angiomas, venous malformations, and
medullary venous malformations [1]. DVA can be located
throughout the brain and have been described as being
juxtacortical, subcortical, or deep. Deep DVA are further
subdivided by supratentorial and infratentorial location [2].
Macroscopically, DVA have been described as dilated thin-
walled medullary vessels that drain white and gray matter
radially and centripetally into a larger caliber collecting or
draining vein that opens into superficial subcortical or deep
pial veins [3, 4].
DVA represent nearly 60% of all cerebral vascular
variations (often classified as malformations) at autopsy
[5]. In a craniospinal magnetic resonance imaging (MRI)
survey of 8,200 patients, DVA were present in 50,
suggesting a point prevalence of 0.6% [6]. A postmortem
study of 4,069 cases reported that DVA were present in
2.5% [7]. DVA are known to be associated with vascular
malformations including arteriovenous malformation
(AVM), cavernous malformations (CM), and capillary
telangiectasias [8, 9]. Up to a third of patients with DVA
may have a second cerebrovascular abnormality, such as
CM [9]. Isolated DVA are considered to be congenital in
nature and generally follow a benign natural history.
However, symptomatic DVA have been increasingly clin-
ically identified [10] and neurologic symptoms, such as
headaches, seizures, paresthesias, motor deficits, trigeminal
neuralgia, and extrapyramidal disorder have been reported
[11].
DVA have been identified on computed tomography
(CT), magnetic resonance imaging (MRI), single photon
emission computed tomography (SPECT), conventional
angiography, and digital subtraction angiography (DSA)
and may display several characteristic imaging features on
each of these modalities. On contrast-enhanced CT, the
linear or curvilinear features of the venous collection
system are frequently present. On noncontrast MR, DVA
can appear as tubular signal voids on T1- and T2-weighted
sequences [8] and variable degrees of T1 and T2 prolon-
gation may be seen in adjacent parenchyma [12]. On
contrast-enhanced MRI, the draining veins enhance to
provide improved visualization of DVA structure. On
diffusion-weighted imaging, DVA that are thrombosed or
infarcted may appear as a region of restricted diffusion with
a bright signal intensity [13]. Perfusion MR studies have
demonstrated increased perfusion values [12, 14]. However,
CT perfusion (CTP) parameters of DVA have only been
recently described [15]. This may be secondary to limi-
tations of whole-brain coverage in previous technology that
did not allow full visualization in the peripheral or superior
cerebral cortices.
Recent advances in the understanding of flow-related
pathomechanisms of DVA include an increased risk of
symptomatology secondary to their in- and outflow
hemodynamics [10]. Hemodynamic changes that can be
detected by imaging may be caused by collecting vein
outflow obstruction, progressive thickening of vein walls,
and structural organization in the venous convergence zone
[16]. DVA with a vascular malformation, arteriovenous
shunting, and an arterialized DVA have been described as
early appearing vessels with a capillary blush in the
arterial phase and early venous filling on angiography
[17]. Such DVA variations may increase the clinical risk of
these lesions and may therefore require more frequent
assessments.
In this study, five cases of DVA, as well as age- and sex-
matched controls, were retrospectively identified on whole-
brain CT DSA and whole-brain CTP to evaluate if the
increased anatomical coverage on whole-brain CTP and the
collection of relative CTP parameters could provide
incremental diagnostic information for DVA identification
and diagnosis.
Materials and methods
This study was a retrospective and anonymized study of CT
scans obtained for clinical purposes. This study was
performed with Institutional Review Board exemption
approval and was Health Information Portability and
Accountability Act compliant.
Demographic data Cases and controls were identified
retrospectively in a consecutive manner from CTP exami-
nations completed without complications or technical fail-
ures between April and December 2008. Clinical
characteristics, CT indications, and DVA descriptions are
listed in Table 1. All scans were considered diagnostic with
excellent definition of DVA vascular structures on CT DSA
and hemodynamic information on CTP.
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The 320-detector row dynamic volume CT technique Scans
were performed on a 320-detector row configuration CT
scanner (Aquilion ONE, Toshiba Medical Systems, Nasu,
Japan). CT imaging protocol, hardware, software, and
perfusion parameters are listed in Table 2. The CT protocol
provided CT angiography (CTA), CT arterial-venous view
(CTA-V), four-dimensional (4D) CT DSA, and whole-brain
CTP. Radiation doses were estimated using the CT console
dose length product (DLP) and converted to effective dose
as milliSieverts (mSv) using the conversion factor for CT of
the head (DLP×0.0023) according to the European Guide-
lines for Multislice CT (Table 2) [18].
Image analysis All clinical data (CTA, CTA-V, 4D DSA,
and CTP) were retrospectively interpreted by two neuro-
radiologists (A.D. with 17 years and W.O. with 26 years of
Table 1 Age- and sex-matched controls (ranging from 2 years older to 7 years younger) were selected if there was no evidence of brain vascular
abnormalities on CTP ordered for clinical indications listed below.
Age (year); sex Clinical CT indication DVA location and description Figures




Control 1 49; female Prior increased T2 signal
in pons on MRI
No abnormalities Fig. 1
Case 2 63; male Carotid bruit preoperative assessment Juxtacortical left frontal lobe DVA with a superficial
collecting vein
Fig. 3
Control 2 62; male Headaches Mild cerebral atrophy consistent with age
Case 3 64; male Prior abnormal CT scan Subcortical right cerebellar hemisphere DVA with 4 dilated
intramedullary veins that converge into a superficial
draining vein near lateral right transverse venous sinus
Fig. 4
Control 3 66; male Rule out vertebral artery stenosis Mild cerebral atrophy consistent with age.
Vertebral artery calcification not causing stenosis
Case 4 28; male Evaluation of a possible AVM
identified on MRI
Subcortical left parietal region DVA and deep collecting vein
Control 4 21; male History of carbon monoxide exposure No abnormalities
Case 5 29; female History of carbon monoxide exposure Left juxtacortical frontal lobe DVA
with a superficial collecting vein
Control 5 29; female History of carbon monoxide exposure No abnormalities
Controls were analyzed to provide baseline values and comparison of case hemispheric CTP values
Table 2 The 320-detector row CT hardware, software, protocol and CTP parameters utilized in this study.
CT configuration 320×0.5 mm detector row
Contrast amount 50-70 ml by automated antecubital venous injection
Contrast infusion rate 4-6 ml/s
Reconstructed section thickness and section interval 0.5 mm with 0.5 mm reconstruction interval
Section collimation 0.5 mm
CT matrix 512×512
Kilovolts (kVp) 80 kVp
Milliamp (mA) 100 mA for 21 individual data sets in cases 1-4. Initial 300 mA
then 100 mA series for 19 individual data sets in case 5
Size of detector array; field of view 160 mm
Software and version Vitrea fX version 2.0.2
Singular value decomposition (SVD) cutoff threshold 5%
Perfusion algorithm utilized SVD+
Vascular pixel elimination On
Dose length product to milliSieverts (mSv) 4.3 mSv for cases 1-4 and 4.4 mSv for case 5
Arterial input function selection location Middle cerebral artery M1 segment
Venous input function location Superior sagittal sinus
Automatic or manual arterial input and venous
input function selections
Manual contralateral unaffected hemisphere for case 1. Automatic arterial
input function and venous input function selection for cases 2-5
Region of interest (ROI) dimensions 8 mm diameter×0.5 mm depth
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neuroradiology experience). Each volume acquisition was
assessed in the cine mode for the presence of motion. No
volumes were removed because of motion, metal, or
artifacts near the DVA. Automatic arterial input function
selections were moved to the contralateral side of the
abnormality if the arterial input function was automatically
placed on the affected side by the software (case 1). Venous
inputs were manually moved to the superior sagittal sinus if
the venous input was automatically positioned near the
DVA (case 3). DVA were assessed by lobar or cerebellar
location and juxtacortical or subcortical depth following the
descriptions of Lee et al. [19]. Juxtacortical was defined as
within the gray matter or within the gray-white matter
junction and subcortical was defined as below the juxta-
cortical region but not adjacent to the ventricular wall. The
draining or collecting vein to which the caput medusae
were joined was classified as either deep toward the
ventricle and central aspects of the brain or superficial
toward the brain surface [19]. No associated CM or other
vascular anomalies were identified.
Analyzed CTP values included regional cerebral blood
volume (CBV), regional cerebral blood flow (CBF), mean
transit time (MTT), time to peak (TTP), and delay. Delay is
a CTP parameter unique to the Vitrea fX software and is
derived computationally from the first identified contrast in
the time-intensity graph and is independent of the contrast
injection rate. Delay is measured as the time in seconds for
the computed residue function to reach maximum. To
collect quantitative CTP values, a template of three regions
of interest (ROI) circles measuring 8 mm in diameter and
0.5 mm thickness were placed 3 mm apart in a triangular
pattern within the DVA at a single axial slice level. Three
ROIs were also placed in the contralateral or unaffected
hemisphere for intraindividual comparison. This identical
bilateral hemisphere ROI template was then placed in the
same location for each control (case 1 and control 1 in
Fig. 1). Absolute values were defined by the ROI CTP
values. Relative values were the percent change in CTP
values between each ROI from one hemisphere and the
contralateral hemisphere. Axial perfusion images for the
five cases were analyzed for absolute and relative values at
the DVA level and compared with the unaffected hemi-
sphere. Hemispheric orientation of the controls was
matched to the affected (i.e., hemisphere with DVA) and
unaffected hemispheric location of each case.
Statistical analysis Analyses of the ROI absolute and
relative values by hemisphere for cases and controls
included maximum, minimum, first quartile (Q1), third
quartile (Q3), median, and outlier CTP values (i.e., value
greater than ±1.5 standard deviation from Q1 and Q3). Box
and whisker diagrams (box plots) were generated to depict
outlier values for absolute and relative CTP values. Grubb's
test analysis confirmed outliers for box plot results as
described by Barnett [20]. Independent t tests assuming
equal variances compared the absolute and relative values.
Absolute values for cases and controls are shown in Fig. 2.
Relative hemispheric comparisons of the three ROIs for
each case and control group are described in Table 3.
Relative case values were calculated for cases by determin-
ing the percentage change between three ROI CTP values
of the affected hemisphere and contralateral or unaffected
hemisphere. Relative control values were calculated for the
five age- and sex-matched controls by maintaining hemi-
spheric alignment with the DVA cases and then comparing
the affected to the unaffected hemisphere values.
Results
Absolute and relative CBV and CBF values were higher for
the five cases in the affected hemisphere compared to the
unaffected hemisphere indicating increased blood volume
and flow within and surrounding the DVA. Relative values
for DVA cases (affected versus unaffected hemisphere) and
relative values for controls with hemispheres of brain
compared in same orientation as the cases were compared
as groups by perfusion parameter using independent two
sample t tests. Statistically significant increases for CBV of
48.28% (p<0.001); 95% CI=29.45-62.75% and for CBF of
31.95% (p<0.001; 95% CI=25.66-57.42%) were present
for the affected hemispheres of the five cases versus their
unaffected hemisphere (Table 3). Three outlier values for
relative CBV and two outliers for CBF within the values
were included in the analyses (Fig. 2a). Relative CBV, CBF,
and MTT for the case affected hemispheres were 45.87%,
37.89%, and 11.11% higher versus the control affected hemi-
spheres, respectively (Table 3).
Relative MTT values for the five cases were significantly
increased on the affected side (26.18%, p=0.004), with the
exception of a single ROI relative value difference of ROI 2
in case 2 (3.3 vs. 3.1; 6.06%) higher on unaffected side.
However, the higher percentage difference in case relative
MTT of 26.18% (case-affected MTT versus case-unaffected
MTT values) versus the relative affected case-to-control MTT
of 11.11% (Table 3) was analyzed further to determine the
source of the spread in these percentages by evaluating the
absolute MTT values (Fig. 2). The difference in the case
affected-to-unaffected absolute MTT values were statistically
significant (p=0.001), while the difference for absolute MTT
values for the case-to-control affected hemispheres was not
statistically significant (p=0.674). Additionally, a comparison
of case-to-control unaffected MTT values had marginal
statistical significance (p=0.058). Median values for the case
unaffected hemispheres was 3.70 s and the median for control
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unaffected hemisphere was 4.60 s, a decrease of 0.90 s.
Comparison of CBV, CBF, TTP, and delay for case-to-control
unaffected absolute values revealed no statistically significant
differences.
Average relative difference for TTP in the five cases was
increased by 0.74% in the affected hemisphere versus the
unaffected side; however, this was not statistically significant
(p=0.377). Case 2 and case 5 had lower TTP values on the
affected side versus contralateral side, suggesting a shorter
arrival time for blood flow. Delay did not have a consistent
pattern of increased or decreased CTP values in the DVA area.
Volumetric surface CTP maps in Fig. 3 demonstrate
cortical-related changes from a left frontal juxtacortical
caput medusa and superficial collecting vein that was
significantly better defined on CTP as compared to the
non-contrast MR obtained in this patient. Figure 4d is a
CTA-V view of the venous phase for case 3 of a subcortical
right cerebellar hemisphere DVA. Effective radiation dose
for cases 1-4 was 4.3 mSv and 4.4 mSv for case 5.
Discussion
This study demonstrates that CTP may permit assessment
of the hemodynamic alterations associated with DVA. For
each DVA in this study, absolute CBV and CBF values
were significantly increased in the affected hemisphere as
compared to the unaffected hemisphere. On MR perfusion,
Camacho et al. [12] also identified increased CBF, CBV,
and MTT in four uncomplicated DVA cases. The authors
concluded that hemodynamic alterations were not associat-
ed with the presenting symptoms of the patients and that the
alterations did not imply a more ominous future outcome
for the DVA. The results of this study suggested that
increased regional CBV and CBF on CTP may indicate
the presence of a DVA on CTP of the brain and case 1
presented with facial numbness symptoms that may have
been influenced by the presence of the DVA. Previous
studies have identified decreased CBF values in the
parenchyma near two large DVA on xenon-enhanced CT
[21] and in one patient on brain perfusion SPECT that the
authors believed was correlated with the SPECT abnor-
malities, DVA location, and an electroencephalograph
focus [22]. However, differentiation of the intravascular
hemodynamic changes and the surrounding parenchymal
perfusion changes using the ROI approach in this study is
limited due to the averaging of the CTP values within the
ROI and future studies using a pixel-by-pixel evaluation of
the DVA and the surrounding parenchyma could provide
an answer.
Fig. 1 Three ROIs measuring 8 mm in diameter and 0.5 mm
thickness were placed 3 mm apart in a triangular pattern within the
affected hemisphere and mirrored in the unaffected hemisphere (case 1
in the upper row; a, b, c). An identical ROI template was used for
each control (control 1 in lower row d, e, f) to facilitate comparisons
of absolute values and relative CTP percentages for regional CBV (a,
d), regional CBF (b, e), and MTT (c, f)
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Although MTT was consistently elevated and suggestive
of delayed or slow flow in this small group of five patients,
further study is required to determine how the whole-brain
hemodynamic (i.e., CBV and CBF) and temporal CTP
values (i.e., MTT, TTP, and delay) within the DVA can be
utilized to further delineate the hemodynamic parameters
for a larger collection of DVA cases. Because MTT is an
indicator of perfusion pressure, the higher MTT values in
the DVA indicated lower flow or perfusion and increased
MTT values have previously been associated with DVA in
four patients on MR perfusion [12]. The unaffected hemi-
spheres of each case appeared to be influencing the relative
percentage change in MTT values, but because of insignif-
icant p values and the small sample size, evaluation of
trends in MTT values in patients with a DVA over time will
require further research.
Fig. 2 Box plots of absolute hemispheric values for three ROIs of CBV,
CBF, and MTT for each case and control group included: a case-affected
hemisphere versus case-unaffected hemisphere, b control-matched
affected versus control-matched hemisphere unaffected, (c) case-
affected versus control affected, and (d) case-unaffected versus control
unaffected. Outlier values (asterisk) are depicted in the CTP parameter
group as applicable. Significant p values are listed in the upper right
corners and near statistical significance is preceded by a pound sign
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TTP results for DVA cases must be interpreted in the
context of each individual patient. TTP was not indicative
of DVA in this study. This was possibly due to the wide
range of DVA types that can both increase and decrease the
time for blood to get to a region. TTP is a temporal
parameter that can be falsely prolonged depending on
technical factors of the scanning process and by the size
and shape of the arterial input function. Cases 1, 3, and 4
had higher relative TTPs in the affected hemisphere (range
1.99-6.45%) that suggested slower arrival of contrast to the
DVA. This may be anticipated in slow flow venous
structures with lower proportions of arterial influence on
TTP values. For cases 2 and 5, rapid flow and lower
relative TTP (−4.09% in case 5 to −7.43% in case 2) in the
affected hemisphere could be interpreted as contribution
from a possible arteriovenous shunting component but this
could not be confirmed and no arterial abnormalities were
noted on CT DSA for cases 2 and 5. Further DVA case
analyses will be required to evaluate if TTP may serve as a
stratifier for CTP pressures in DVA and a possible CTP
parameter that may, in combination with the CBV, CBF,
and MTT results, help to delineate an individual’s risk of
future complications.
Flow-related complications of DVA that may lead to a
symptomatic presentation include an increase of inflow
because of an arteriovenous shunt, a decrease of outflow, or
a remote shunt with increased venous pressure [10]. In our
study, case 1 presented with symptoms that was possibly
secondary to a DVA (Fig. 5). Pereira et al. suggested
characteristics of an increased risk of symptomatic DVA
presentation: large and complex DVAwith changes on MRI
suggesting venous congestion, acute or subacute ischemic
changes, asymmetrical medullary zone appearance, and
association with AVMs [10]. Mechanical compression of
intracranial structures around the DVA produced symptoms
in 20.3% (14 of 69 cases). Unexplained symptomatology
occurred in 8.7% (six of 69 cases) while the remaining 71%
(49 of 69 cases) of symptomatic DVA were attributed to
flow-related pathomechanisms (19 with increased inflow,
26 with decreased outflow, and four with a shunt that
Fig. 3 Volumetric surface CT perfusion maps from case 2 of cortical changes (arrows) in regional CBV (a), regional CBF (b), and MTT (c)
related to a left frontal juxtacortical DVA with a superficial collecting vein
Table 3 Analyses of the hemispheric comparisons of the aggregated
ROI CTP values for case versus control group included: (1) case
affected percent change versus case unaffected (relative case), (2)
control affected percent change versus control unaffected (relative
control); (3) case affected percent change versus control affected
(relative affected); and (4) case unaffected percent change versus
control unaffected (relative unaffected).
Hemispheric Comparison CBV CBF MTT TTP Delay
Case affected versus 48.28%* 31.95%* 26.18%* 0.60% −4.93%
Case unaffected
P values *4.45 x 10−6 *1.05 x 10−5 *4.27 x 10−3 3.77 x 10-1 5.64 x 10−1
Control affected versus 2.17% −9.59% 9.18% −2.89% 2.27%
Control unaffected
Case affected versus 45.87% 37.89% 11.11% −5.71% 0.18%
Control affected
Case unaffected versus 0.73% −16.75% 22.46% 2.83% −5.89%
Control unaffected
P values are listed for case affected and unaffected hemisphere comparisons and statistical significance is indicated by an asterisk (*)
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increased venous pressure) [10]. The findings of the present
study suggest that anatomical variations in DVA that can
influence hemodynamic flow may be characterized by the
combination of assessment by CTA-V (Fig. 4d), whole-
brain dynamic volume CTP, and 4D DSA.
As reviewed by Hammoud et al. [13], nonhemorrhagic
ischemia associated with DVA is uncommon and rarely
reported in the literature. A review by Hon et al. [23] of 15
studies that included 714 patients with DVA found that less
than 1% were associated with infarction on the initial
presentation. The etiology of nonhemorrhagic infarcts
associated with DVA has been proposed as thrombosis of
the collecting or draining vein [13] and has been identified
on angiography [24]. Stenosis at the dural opening of DVA
is also frequently noted and this has been proposed as a
mechanism for initiating a DVA thrombosis [4, 25]. In this
study, no case had clinically discernible stenosis, but case 3
had multiple terminal draining veins that lead into a small
dural opening (Fig. 4a, d). DVA that demonstrate throm-
botic complications are treated the same as cortical venous
or venous sinus thromboses. An identical laboratory
workup is required and consideration for treatment with
anticoagulation is appropriate. Investigation of procoagulat-
ing factors or prothrombotic conditions is also important
[10]. Regardless of the treatment method implemented, it is
important that the integrity of the DVA be preserved to
avoid the substantial neurologic complications previously
documented when it is excised either inadvertently or due
to clinical necessity [10, 13, 26]. DVA-associated hemor-
rhagic and nonhemorrhagic infarctions are rare, but
implementation of prevention measures upon identification,
such as hydration in warm climates, smoking cessation, or
anticoagulant medications for individuals at increased risk
of thrombosis as indicated may reduce risk of adverse
events.
Although DVA complications are rare, the complications
of DVA are more frequently hemorrhagic than ischemic in
nature [25, 27, 28]. The Hon et al. [23] review found that
6% with DVA presented with symptomatic hemorrhage and
the hemorrhage rate following the first event was 0-1.28%
per year for 422 of these 714 patients. In a prospective
study by the same authors on 93 adults, one patient
presented with symptomatic hemorrhage and there were
no symptomatic hemorrhages following the first presenta-
tion for a total of 492 person-years of follow-up [23].
Formation of a thrombus within a DVA has also been
proposed as a cause of DVA-associated hemorrhage
secondary to increased venous pressure [27]. Additionally,
DVA hemorrhages may not result from the DVA itself but
may be associated with co-occurring or developing anoma-
lies including CM, capillary telangiectasias, and AVMs.
Hemorrhage of DVA with an associated CM has been well-
documented [1, 7, 9, 16, 29, 30] and Hong et al. [14]
described angioarchitectural factors of DVA that may cause
Fig. 4 (a) A 64-year-old male
with a subcortical right cerebel-
lar hemisphere DVA on the right
side (case 3) on axial DSA.
Increased CTP values are pres-
ent in the affected hemisphere
(arrows) for regional CBV (b),
regional CBF (e), and MTT (f)
relative to the unaffected
hemisphere. No significant dif-
ferential TTP values were pres-
ent (c). Orthogonally edited
CTA-V view of the venous
system, demonstrating the cere-
bellar hemisphere DVA on the
right side with dilated intrame-
dullary veins that converge into
a collecting vein that enters the
lateral aspect of the right trans-
verse venous sinus is
demonstrated (d)
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concurrent sporadic CM to form. Further evaluation is
required to determine if DVA progression to capillary
telangiectasias and CMs or AVM proximity to DVAs can be
longitudinally monitored with CTP.
Previous CT technology has not allowed whole-brain
visualization and as demonstrated in this study, compre-
hensive DVA analysis requires whole-brain CTP for
visualization of the peripheral or superior cerebral cortices
(case 1 in Fig. 5; cases 2, 4, and 5) or in the posterior fossa
(case 3 in Fig. 4).
With the recent scientific advances in understanding of
the pathophysiology [10] and angioarchitectural factors
[14] of DVA coupled with the increasing clinical availabil-
ity of whole-brain CTP, this preliminary study data
indicates that the incremental diagnostic information for
DVA can be provided by whole-brain CTP studies. Further
investigations are required to use CTP as a method for
identifying individuals at greatest risk for adverse clinical
outcomes related to DVA. Additionally, it is possible that
assessment of the CTP parameters associated with DVA
may help to avoid incorrect diagnoses such as arterial
infarcts, focal hemorrhage, demyelinating disease [31],
neoplasm, or similar appearing abnormalities on CT [13].
Misdiagnosis of DVA and DVA-associated infarcts has
been documented and may be secondary to the heteroge-
neous imaging characteristics of cerebral venous infarctions
[32]. Additionally, DVA are frequently not identified on
other imaging studies including non-contrast CT and
structural MRI but may be detected with CTP, as was true
of case 5 in this study (Table 1).
In order to assess the risk associated with diagnostic
procedures, both physical risk and radiation dose must be
considered. Due to its interventional nature, conventional
angiography has a 0.5% risk of permanent neurologic
complication [33] and a typical effective radiation dose of
10.6 mSv [34]. The whole-brain CT imaging protocol used
in this study, that included CT DSA and CTP, had an
effective dose of 4.3-4.4 mSv (Table 2). Effective radiation
dose for 64-slice CTP has been reported as 7.5-11.4 mSv
[34]. The whole-brain CTP protocol used in this study is
lower than conventional angiography or 64-slice CT and is
less than one third of the level reported as acceptable by the
FDA for brain perfusion imaging [35]. As with any imaging
study, the benefit of the diagnostic information acquired
must always be weighed versus the radiation risk.
There were limitations of this study. CTP value variation
using ROIs and placement of the ROIs near vessels or
artifacts can adversely impact the clinical interpretation of
results. Variation with the 8 mm ROIs was increased for
two reasons: (1) a HU densities in the ROI are averaged in
the vicinity of each voxel together and (2) when the ROI is
placed in areas with vessels, the flow and volumes are
significantly higher. CTP values obtained within the area of
the DVA and in the contralateral hemisphere have different
compositions of parenchymal and vascular components and
this variability could not be quantified. Vascular and tissue
Fig. 5 A 50-year-old female
who presented with numbness
on the right side of her face
(case 1); a juxtacortical left
frontal lobe DVA was identified.
a Upper left axial image is a
DSA image collected with slice
thickness of 30 mm and then
clockwise from left to right axial
perfusion images are colorimet-
ric representations of b regional
CBV, c TTP, d regional CBF, e
MTT, and f delay
Neuroradiology (2011) 53:331–341 339
differentiation could be improved by pixel-by-pixel CTP value
evaluations and this could increase precision in defining the
range of CTP values at important DVA structures, such as the
terminal vein opening. Additionally, no cases had angio-
graphical confirmation of associated pathologies. Finally,
expanded CTP studies with higher numbers of patients using
standardized system configurations (e.g., hardware, software,
and protocols) with human variables (e.g., estimates of cardiac
output and hematocrit) incorporated into the DICOM files may
help to facilitate individual CTP analyses, as well as compar-
isons between individuals.
Most DVA are incidental findings on imaging studies and
little is known about which individuals will progress to
hemorrhagic or ischemic complications. The cases presented
suggest that the physiologic appearance of DVA on CT DSA
and whole-brain CTP can provide incremental clinical infor-
mation to practitioners for diagnostic purposes and with future
research may help to provide some of the monitoring and
prognostic data required to identify the rare subset of patients
with DVA that are at increased risk of adverse outcomes.
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